CESAR and UMD Receives $6M+ of New Funding for Substance Use Treatment Research
CESAR Receives Grant to Create Digital Hub Serving Peer Recovery Specialists in Maryland
MD-EDDS: Xylazine Detected in 8% of Positive Specimens from Meritus Medical Center; All Contained Fentanyl
CESAR Director Jessica Magidson Named an MPower Professor
Roads to Recovery: Mobile Treatment Units Bring Help and Hope To Rural Maryland
Applying a mutual capacity building model to inform peer provider programs in South Africa and the United States
UMD-led System Shows Success in Helping Hospitals Understand Fentanyl Use in their Communities
Xylazine Now Included in CESAR EDDS Urine Drug Test Panels
Jessica Magidson Named New Director of CESAR, Now the ‘Center for Substance Use, Addiction & Health Research’